EICHORCondition: Major Depressive Disorder · Depression · Sponsor: Levomecor Inc.
A Phase 3, randomized, double-blind, placebo-controlled, multicenter trial of REL-1017 in patients with major depressive disorder (MDD).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Body mass index (BMI) between 18.0 and 35.0 kg/m2. * Diagnosed with Major Depressive Disorder (MDD) based on Structured Clinical Interview for DSM-5 (SCID-5) for MDD. * Inadequate response to 1 to 3 adequate antidepressant treatments in the current MDE. Exclusion Criteria: * Psychiatric hospitalization during the current major depressive episode. * History or presence of clinically significant health conditions which in the opinion of the Investigator would negatively impact the safety of the participant. * Participants who, in the Investigator's judgment, are at significant risk for suicide. * Pregnant or planning to become pregnant.
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Relmada Site | Dothan, Alabama, United States | — |
| Relmada Site | Homewood, Alabama, United States | — |
| Relmada Site | Anaheim, California, United States | — |
| Relmada Site | Lafayette, California, United States | — |
| Relmada Site | Newport Beach, California, United States | — |
| Relmada Site | Orange, California, United States | — |
| Relmada Site | Redlands, California, United States | — |
| Relmada Site | Sherman Oaks, California, United States | — |
| Relmada Site | Farmington, Connecticut, United States | — |
| Relmada Site | Brandon, Florida, United States | — |
| Relmada Site | Hialeah, Florida, United States | — |
| Relmada Site | Jacksonville, Florida, United States | — |
+ 24 more locations — full list on the registry record.
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06011577